The Antiallodynic Effects of Nefopam Are Mediated by the Adenosine Triphosphate–Sensitive Potassium Channel in a Neuropathic Pain Model
Authors:
- Jin Woo ShinJSJin Woo Shin
- Ji-Yeon BangJBJi-Yeon Bang
- Sae Gyeol KimSKSae Gyeol Kim
- Jun-Gol SongJSJun-Gol Song
- 1 September 2016
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 123 (3) , 762-770
Abstract
BACKGROUND: Nefopam hydrochloride is a centrally acting compound that induces antinociceptive and antihyperalgesic properties in neuropathic pain models. Previous reports have shown that activation of adenosine triphosphate (ATP)-sensitive and calcium-activated potassium (KATP and KCa2+) channels has antiallodynic effects in neuropathic pain. In the present study, we evaluated the relationship between potassium channels and nefopam to determine whether the antiallodynic effects of nefopam are mediated by potassium channels in a neuropathic pain model. METHODS: Mechanical allodynia was induced by spinal nerve ligation (SNL) in rats, and the paw withdrawal threshold (PWT) was evaluated by the use of von Frey filaments. Nefopam was administered intraperitoneally before or after SNL. We assessed the relationship between nefopam and intrathecal injection of the KCa2+ channel antagonists apamin and charybdotoxin, and the KATP channel blocker glibenclamide to assess their abilities to reverse the antiallodynic effects of nefopam. In addition, we evaluated whether the KATP channel opener pinacidil had antiallodynic effects and promoted the antiallodynic effects of nefopam. RESULTS: Administration of nefopam before and after SNL induced significant antiallodynic effects (P < .01, respectively), which were significantly reduced by glibenclamide (P < .01). Pinacidil improved the antiallodynic effects of nefopam (P < .01); however, apamin and charybdotoxin had little effects on the antiallodynic properties of nefopam. CONCLUSIONS: The antiallodynic effects of nefopam are increased by a KATP channel agonist and reversed by a KATP channel antagonist. These data suggest that the KATP channel is involved in the antiallodynic effects of nefopam in a neuropathic pain model.Keywords
This publication has 40 references indexed in Scilit:
- Systematic evaluation of the nefopam–paracetamol combination in rodent models of antinociceptionClinical and Experimental Pharmacology and Physiology, 2011
- Nefopam for the prevention of postoperative pain: quantitative systematic reviewBritish Journal of Anaesthesia, 2008
- Neuronal Sensitization and Its Behavioral Correlates in a Rat Model of Neuropathy Are Prevented by a Cyclic Analog of OrphenadrineJournal of Neurotrauma, 2003
- Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the ratPharmacological Research, 2001
- Chronic Neuropathic Pain and Its Control by DrugsPharmacology & Therapeutics, 1997
- Evaluation of nefopam as a monoamine uptake inhibitor in vivo in miceNeuropharmacology, 1993
- Antinociceptive effects of (±)-, (+)- and (-)-nefopam in miceJournal of Pharmacy and Pharmacology, 1987
- Conformation of Nefopam Hydrochloride, a Novel AnalgesicJournal of Pharmaceutical Sciences, 1986
- Spinal and supraspinal sites for morphine and nefopam analgesia in the mouseEuropean Journal of Pharmacology, 1981
- NefopamDrugs, 1980